Fund Holdings — MPM BioImpact LLC

Total Portfolio Value:
$581.68M
Total Bought:
$190.16M
Total Sold:
$149.30M
Net Transaction:
+$40.86M
Notable People:
Ansbert K Gadicke
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Cullinan Therapeutics, Inc.(CGEM)7,648,2687,648,2680$93.16M$57.90M9.95%-$35.26M
Madrigal Pharmaceuticals, Inc.(MDGL)0100,415+100,415$0$33.26M5.72%+$33.26M
Zai Lab LimitedADR(ZLAB)800,000833,659+33,659$20.95M$30.13M5.18%+$9.18M
Edgewise Therapeutics, Inc.(EWTX)1,079,3161,105,444+26,128$28.82M$24.32M4.18%-$4.50M
Lantheus Holdings, Inc.(LNTH)236,213232,387-3,826$21.13M$22.68M3.90%+$1.55M
PTC Therapeutics, Inc.(PTCT)434,767439,977+5,210$19.63M$22.42M3.85%+$2.80M
Natera, Inc.(NTRA)160,626157,047-3,579$25.43M$22.21M3.82%-$3.22M
Trevi Therapeutics, Inc.(TRVI)3,094,8963,428,366+333,470$12.75M$21.56M3.71%+$8.81M
Crinetics Pharmaceuticals Inc.617,035631,964+14,929$31.55M$21.20M3.64%-$10.35M
Avidity Biosciences Inc702,981714,224+11,243$20.44M$21.08M3.62%+$641.2K
Guardant Health, Inc.(GH)452,739442,656-10,083$13.83M$18.86M3.24%+$5.03M
United Therapeutics Corporation(UTHR)23,00058,907+35,907$8.12M$18.16M3.12%+$10.04M
ARS Pharmaceuticals, Inc.(SPRY)01,313,104+1,313,104$0$16.52M2.84%+$16.52M
Compass Therapeutics, Inc.(CMPX)8,567,8968,442,783-125,113$12.42M$16.04M2.76%+$3.62M
Janux Therapeutics, Inc.(JANX)230,000567,193+337,193$12.31M$15.31M2.63%+$3.00M
Ultragenyx Pharmaceutical Inc.(RARE)391,018398,445+7,427$16.45M$14.43M2.48%-$2.02M
MoonLake ImmunotherapeuticsCL A(MLTX)315,230316,049+819$17.07M$12.35M2.12%-$4.72M
Wave Life Sciences, Inc.(WVE)1,489,2371,509,580+20,343$18.42M$12.20M2.10%-$6.22M
Revolution Medicines, Inc.(RVMD)313,817317,083+3,266$13.73M$11.21M1.93%-$2.51M
Alkermes plc(ALKS)0337,603+337,603$0$11.15M1.92%+$11.15M
Olema Oncology, Inc.(OLMA)2,912,5502,930,446+17,896$16.98M$11.02M1.89%-$5.96M
Rocket Pharmaceuticals, Inc.(RCKT)1,020,5591,618,265+597,706$12.83M$10.79M1.86%-$2.03M
iTeos Therapeutics, Inc.1,745,9431,745,9430$13.41M$10.42M1.79%-$2.99M
Cartesian Therapeutics, Inc.(RNAC)721,139790,779+69,640$12.92M$10.42M1.79%-$2.49M
Twist Bioscience Corporation(TWST)267,497261,215-6,282$12.43M$10.26M1.76%-$2.18M
Xenon Pharmaceuticals Inc.(XENE)197,212303,398+106,186$7.73M$10.18M1.75%+$2.45M
Vera Therapeutics, Inc.CL A(VERA)257,788415,719+157,931$10.90M$9.99M1.72%-$916.3K
Replimune Group, Inc.(REPL)950,000987,036+37,036$11.50M$9.62M1.65%-$1.88M
Iovance Biotherapeutics, Inc.(IOVA)2,673,9052,708,582+34,677$19.79M$9.02M1.55%-$10.77M
Context Therapeutics Inc.(CNTX)14,705,88214,705,8820$15.44M$9.00M1.55%-$6.44M
MBX Biosciences, Inc.(MBX)01,132,950+1,132,950$0$8.36M1.44%+$8.36M
Nuvation Bio Inc.(NUVB)4,164,1784,652,243+488,065$11.08M$8.19M1.41%-$2.89M
ORIC Pharmaceuticals, Inc.(ORIC)01,399,514+1,399,514$0$7.81M1.34%+$7.81M
IDEAYA Biosciences, Inc.(IDYA)414,035430,161+16,126$10.64M$7.05M1.21%-$3.59M
Solid Biosciences Inc01,642,356+1,642,356$0$6.08M1.04%+$6.08M
Relay Therapeutics, Inc.(RLAY)2,268,8252,295,924+27,099$9.35M$6.02M1.03%-$3.33M
Stoke Therapeutics, Inc.(STOK)685,826693,988+8,162$7.56M$4.62M0.79%-$2.95M
Veru Inc.(VERU)4,285,3656,592,727+2,307,362$2.79M$3.23M0.56%+$443.5K
Werewolf Therapeutics, Inc.(HOWL)2,388,0112,408,810+20,799$3.53M$2.34M0.40%-$1.19M
Design Therapeutics, Inc.(DSGN)559,547562,943+3,396$3.45M$2.17M0.37%-$1.28M
Adaptimmune Therapeutics plcADR(ADAPY)5,095,9124,894,344-201,568$2.75M$964.2K0.17%-$1.78M
Repare Therapeutics, Inc.1,231,154819,924-411,230$1.61M$808.4K0.14%-$804.4K
ALX Oncology Holdings Inc.(ALXO)1,391,434550,000-841,434$2.32M$342.6K0.06%-$1.98M
Akero Therapeutics Inc460,6170-460,617$12.81M$0—-$12.81M
Aquestive Therapeutics Inc1,611,8330-1,611,833$5.74M$0—-$5.74M
Arcturus Therapeutics Holdings Inc.(ARCT)459,9430-459,943$7.81M$0—-$7.81M
Axsome Therapeutics, Inc.(AXSM)50,0000-50,000$4.23M$0—-$4.23M
Disc Medicine, Inc.(IRON)346,4010-346,401$21.96M$0—-$21.96M
Insmed Incorporated(INSM)389,6110-389,611$26.90M$0—-$26.90M
Mirum Pharmaceuticals, Inc.(MIRM)589,5790-589,579$24.38M$0—-$24.38M
Scholar Rock Holding Corporation(SRRK)416,1440-416,144$17.99M$0—-$17.99M
Sutro Biopharma, Inc.(STRO)2,160,0620-2,160,062$3.97M$0—-$3.97M
Zentalis Pharmaceuticals, Inc.(ZNTL)1,106,8510-1,106,851$3.35M$0—-$3.35M
Page 1 of 1
MPM BioImpact LLC — 13F Holdings — Q1 2025 | TickerTrail